RGA:NYSEReinsurance Group of America, Incorporated Analysis

RGA trades at $209.66, roughly 5% below its 20‑day SMA of 207.67 and just under the 50‑day SMA of 209.18, indicating a modest upside cushion. The stock’s forward P/E of 7.3 and current P/E of 11.8 are well beneath the industry average of 17.5, suggesting it is priced cheaply relative to peers. A DCF‑derived fair value of about $997 and an implied upside of ~18% reinforce the undervaluation thesis. Revenue growth of 26.6% and a forward EPS estimate of $28.87 point to strong top‑line momentum. The dividend has been raised and now yields 1.77% with a modest payout ratio of 21%, underscoring sustainability. MACD is bullish and RSI sits at a neutral 53.8, while support at $198.48 and resistance near $214 frame a tight trading range.
Volatility over the past 30 days sits at 18.7% and beta is only 0.72, implying moderate price swings but lower market sensitivity. The company’s net debt position is modest, with $5.8 B of debt offset by $4.5 B of cash, and a debt‑to‑equity of 43% is manageable for a reinsurer. Geographic diversification across North America, Europe, Asia‑Pacific and the Middle East spreads risk, while regulatory exposure remains typical for the insurance sector. The Fear & Greed Index reading of “Extreme Greed” reflects strong market appetite, yet the recent one‑month price decline of ~9.7% offers a buying opportunity. Analyst consensus of “Buy” from nine contributors, with a median target of $261, adds further confidence. Taken together, the fundamentals, valuation headroom, and dividend outlook support a buy recommendation across horizons.